# Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant

> **NCT03589040** · PHASE2 · UNKNOWN · sponsor: **Makerere University** · enrollment: 60 (estimated)

## Conditions studied

- HIV
- Contraception

## Interventions

- **DRUG:** Etonogestrel 68Mg Implant
- **DRUG:** rilpivirine
- **DRUG:** darunavir

## Key facts

- **NCT ID:** NCT03589040
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-25
- **Primary completion:** 2019-06
- **Final completion:** 2020-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-03-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03589040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03589040, "Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03589040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*